Photo of Rosa L. DeLauro
D United States House · District 3 · Connecticut On the 2026 ballot

Rep. Rosa L. DeLauro

Compare
Total votes
2,837
all sessions
Attendance
99%
32 missed
Near the chamber average
With party
98%
of cast votes
Higher than 82% of chamber peers
Bipartisan score
1%
crosses aisle rarely
Lower than 83% of chamber peers
Sponsored
814
bills & resolutions
Near the chamber average
Committees
2
assignments
814 bills and resolutions

Sponsored bills

Total
814
Primary
142
Co-sponsor
672
This page
814
matching current filters
Primary HJRES 75
Signed into law · United States House · Lead sponsor
Extension of Continuing Appropriations Act, 2022

Extension of Continuing Appropriations Act, 2022 This joint resolution provides continuing FY2022 appropriations to federal agencies through March 15, 2022. It is known as a continuing resolution (CR) and prevents a government shutdown that would otherwise occur if the FY2022 appropriations bills have not been enacted when the existing CR expires on March 11, 2022. The joint resolution also (1) extends the temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances in Schedule I of the Controlled Substances Act, and (2) increases the limit on the value of the defense articles and services that the President is authorized to draw down to address unforeseen emergencies.

Signed into law Mar 11, 2022 0 co-sponsors
Co-sponsor HR 7061
In committee · United States House · Co-sponsor
Big Oil Windfall Profits Tax Act

Big Oil Windfall Profits Tax Act This bill imposes an excise tax on the windfall profits of crude oil on taxpayers who extracted and imported more than 300,000 barrels (a barrel equals 42 U.S. gallons) of taxable crude oil (i.e., crude oil, crude oil condensates, and natural gasoline) in 2019, or who extracted and imported that amount in the current calendar quarter. The bill requires rebates of the tax collected to be paid to individual taxpayers. The bill establishes the Protect Consumers from Gas Hikes Fund to finance such rebates.

In committee Mar 11, 2022 1 co-sponsor
Primary HR 7007
Passed · United States House · Lead sponsor
COVID Supplemental Appropriations Act, 2022

COVID Supplemental Appropriations Act, 2022 This bill provides FY2022 supplemental appropriations to several federal departments and agencies for programs and activities to respond to COVID-19. Specifically, the bill provides appropriations to the Department of Health and Human Services, the Department of State, the U.S. Agency for International Development, and the President. The bill also rescinds specified unobligated funds from several accounts.

Passed Mar 9, 2022 0 co-sponsors
Co-sponsor HRES 881
Passed · United States House · Co-sponsor
Condemning the heinous terrorist attack on Congregation Beth Israel in Colleyville, Texas, on January 15, 2022.

This resolution condemns the terrorist attack on Congregation Beth Israel in Colleyville, Texas, on January 15, 2022. It also expresses support for the affected community, commends the actions of law enforcement and emergency responders, and reaffirms a commitment to combat hate, bigotry, anti-Semitism, and violence against Jewish Americans.

Passed Mar 8, 2022 1 co-sponsor
Co-sponsor HR 6938
In committee · United States House · Co-sponsor
Job Protection Act

Job Protection Act This bill reduces from 12 months to 90 days the employment period required for employees (including federal employees) to become eligible for family and medical leave. Additionally, the bill makes the family and medical leave requirements applicable to all employers (currently, the requirements apply to employers with 50 or more employees).

In committee Mar 3, 2022 1 co-sponsor
Co-sponsor HR 6904
In committee · United States House · Co-sponsor
Patients Before Profits Act of 2022

Patients Before Profits Act of 2022 This bill prohibits a group health insurance plan and a health insurance issuer offering group or individual health insurance coverage from reducing contracted rates or terminating contracts with health care providers during a public health emergency period.

In committee Mar 3, 2022 1 co-sponsor
Primary HR 6834
In committee · United States House · Lead sponsor
Recall Unsafe Drugs Act of 2022

Recall Unsafe Drugs Act of 2022 This bill authorizes the Food and Drug Administration (FDA) to order the recall of certain adulterated or misbranded drugs and contains other related provisions. A producer of a medication must notify the FDA of the identity and location of a drug if the producer has reason to believe that (1) the drug is adulterated or misbranded, and (2) there is a reasonable probability that the drug will cause a threat of serious adverse health consequences or death to humans or animals. If use of a drug may cause serious adverse health consequences or death, the FDA may order the producer to immediately cease distribution and notify affected individuals. After issuing such an order, the FDA may also order a recall after affording the producer an opportunity for an informal hearing. If a drug presents an imminent threat of serious adverse health consequences or death, the FDA may order the producer to immediately recall the drug and notify affected individuals. The distributor may appeal such an order. An individual or entity required to register as a producer of drugs or medical devices must have a recall plan in effect.

In committee Feb 28, 2022 0 co-sponsors
Co-sponsor HR 3755
Passed · United States House · Co-sponsor
Women's Health Protection Act of 2021

Women's Health Protection Act of 2021 This bill prohibits governmental restrictions on the provision of, and access to, abortion services. Specifically, governments may not limit a provider's ability to prescribe certain drugs, offer abortion services via telemedicine, or immediately provide abortion services when the provider determines a delay risks the patient's health. Furthermore, governments may not require a provider to perform unnecessary medical procedures, provide medically inaccurate information, comply with credentialing or other conditions that do not apply to providers whose services are medically comparable to abortions, or carry out all services connected to an abortion. In addition, governments may not (1) require patients to make medically unnecessary in-person visits before receiving abortion services or disclose their reasons for obtaining such services, or (2) prohibit abortion services before fetal viability or after fetal viability when a provider determines the pregnancy risks the patient's life or health. The bill also prohibits other governmental measures that are similar to the bill's specified restrictions or that otherwise single out and impede access to abortion services, unless a government demonstrates that the measure significantly advances the safety of abortion services or health of patients and cannot be achieved through less restrictive means. The Department of Justice, individuals, or providers may bring a lawsuit to enforce this bill, and states are not immune from suits for violations. The bill applies to restrictions imposed both prior and subsequent to the bill's enactment.

Passed Feb 28, 2022 1 co-sponsor
Co-sponsor HR 6835
In committee · United States House · Co-sponsor
No Most Favored Nation Trading with Russia Act

No Most Favored Nation Trading with Russia Act This bill withdraws normal trade relations treatment from Russia. Additionally, the bill requires the President to encourage U.S. allies and partners to (1) consider taking similar actions; and (2) condemn, at the World Trade Organization (WTO), Russia's aggression in Ukraine. Further, the President must direct the U.S. Permanent Representative to the WTO to seek suspension of Russia's membership in the WTO.

In committee Feb 25, 2022 1 co-sponsor
Showing 611 to 620 of 814 bills
Previous 1 … 61 62 63 … 82 Next